What Tiger Kandu LLC does

Tiger Kandu LLC (operating as Kandu, Inc.) is a US neurotechnology company formed in March 2025 through the merger of Kandu Health and Neurolutions, headquartered in Los Angeles and operating through wholly-owned subsidiaries including Neurolutions, Kandu Health, and affiliated professional corporations (Kandu Medical Services East PC and West PC). The company addresses the more than 20 million people living with stroke in the United States, with a focus on chronic upper-extremity paralysis where effective rehabilitation options are limited.

Kandu's core product is the IpsiHand Brain-Computer Interface, the first FDA-cleared BCI for stroke rehabilitation, which received De Novo market authorization as a breakthrough-designated device in April 2021. IpsiHand uses non-invasive EEG to detect theta-gamma coupling as a cortical biomarker, translates motor intention into commands, and drives a robotic hand exoskeleton for at-home therapy. Kandu Health provides a complementary telehealth-based Principal Illness Navigation and recovery support service for stroke survivors and their care partners, with the stated goal of reducing rehospitalization and improving quality of life. Clinical evidence supporting the platform includes a 62-patient randomized controlled trial stopped early for efficacy (6-point mean Fugl-Meyer improvement vs. 1.5 in control; 55.5% clinically meaningful response vs. 9.6%; NNT of 2.2) and 100-patient outcomes presented at ISC 2024 showing over 50% reduction in inpatient readmissions versus published ranges.

The business model combines hardware sales of IpsiHand as physician-prescribed durable medical equipment reimbursed through healthcare payers with managed-service revenue from Principal Illness Navigation offered to healthcare systems and payers. Kandu is privately held, with no disclosed funding rounds or revenue, and the company has not yet disclosed specific pricing, payer contracts, or unit volumes. Its go-to-market is enterprise field sales complemented by KOL engagement at medical conferences such as the International Stroke Conference.

Name

Tiger Kandu LLC

Legal name

Kandu, Inc.

Website

https://kandu.com

Company type

Private

Founded year

2025

Operating status

Operating

Short description

Kandu (Tiger Kandu LLC) is a US neurotechnology company that sells the FDA-cleared IpsiHand brain-computer interface for chronic stroke rehabilitation and delivers Principal Illness Navigation telehealth services to stroke survivors, care partners, healthcare systems, and payers.

Ownership category

akta.pro rank

Product category

Neurotechnology Medical Devices

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Services for the Elderly and Persons with Disabilities (62412)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Home Health Care Services (8082), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industries

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK), Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s) (HSABADAE), Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)

Keywords

• Brain-computer interface therapy
• Stroke rehabilitation devices
• Neurotechnology medical devices
• Telehealth navigation services
• Post-acute care recovery

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. IpsiHand BCI Device Sales: The FDA-cleared IpsiHand brain-computer interface is sold as prescribed durable medical equipment for at-home use by chronic stroke survivors. Revenue is generated through healthcare system and payer reimbursement channels.
2. Kandu Health Clinical Navigation Services: Outpatient Principal Illness Navigation and recovery support services provided to stroke survivors and care partners. Kandu Health provides services to healthcare systems and payers, with the goal of improving quality of life and reducing rehospitalization likelihood.
3. Kandu Medical Services: Medical services offered through affiliated professional corporations (Kandu Medical Services East PC and Kandu Medical Services West PC), providing clinical oversight and patient care coordination.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Kandu develops and commercializes the FDA-cleared IpsiHand brain-computer interface system, a non-invasive EEG-driven robotic hand exoskeleton for upper-extremity motor recovery in chronic stroke survivors. The company complements the hardware with telehealth-based Principal Illness Navigation and clinical recovery support services (Kandu Health), providing integrated at-home stroke rehabilitation solutions to patients, healthcare systems, and payers.

Product overview

Kandu Inc. (Tiger Kandu LLC) is a neurotechnology company formed from the merger of Neurolutions and Kandu Health in March 2025. The company offers a dual-pronged approach to stroke recovery: (1) the IpsiHand Brain-Computer Interface — an FDA-cleared medical device for upper-extremity motor rehabilitation that uses neural signals to enable functional hand movement, and (2) Kandu Health services — telehealth-based Principal Illness Navigation and recovery support. These products work synergistically: the IpsiHand BCI provides the hardware technology while Kandu Health delivers the clinical services and survivor communities, creating a comprehensive at-home stroke recovery solution combining breakthrough technology with personalized care.

Differentiator

Problem solved

Functional benefit

Brands

• Neurolutions: Dedicated to transforming lives of patients suffering from neurological conditions through IpsiHand, a breakthrough brain-computer interface device for hand function recovery after stroke or brain injury
• IpsiHand
• Kandu Medical Services

Products and services

• IpsiHand Brain-Computer Interface System FDA-cleared brain-computer interface medical device that uses non-invasive EEG-based neural signals to detect motor intention and trigger a robotic hand exoskeleton with functional electrical stimulation for upper-extremity motor recovery in chronic stroke survivors. Sold as prescribed durable medical equipment for at-home use.
• Kandu Health Clinical Navigation Services Telehealth-based outpatient Principal Illness Navigation and recovery support services for stroke survivors and their care partners, designed to reduce rehospitalization and improve quality of life. Provided to healthcare systems and payers to ensure stroke patients receive necessary recovery resources.
• Kandu Medical Services Clinical medical services delivered through affiliated professional corporations (East PC and West PC), providing clinical oversight, Principal Illness Navigation, and recovery support for stroke survivors enrolled in Kandu programs.

Quantifiable outcome

• 55.5% of BCI therapy patients achieved clinically meaningful response vs 9.6% in control arm; number needed to treat of 2.2
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability1 record

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Washington University in St. LouiscoreStrategic or Co-development Partner · 1 March 2025Dr. Eric Leuthardt, founder of Neurolutions and Chief Scientific Officer of Kandu, holds positions in Neurological Surgery, Neuroscience, Biomedical Engineering, Mechanical Engineering, and Material Sciences at Washington University. He serves as Chief of the Division of Neurotechnology. This academic partnership has enabled development of BCI technology and motor network reorganization research.
• Cooper University HospitalcoreStrategic or Co-development PartnerDr. Tudor Jovin, Chief Medical Officer of Kandu, is based at Cooper University Hospital in Camden, New Jersey, and serves as Chief and Chairman of Cooper Neurological Institute. His expertise in stroke treatment and research strengthens Kandu's clinical credibility.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Saebo: Saebo is a direct peer in stroke rehabilitation devices, offering a range of upper-extremity products (SaeboGlove, SaeboReach, SaeboFlex) prescribed for stroke survivors with hand and arm dysfunction. Highly comparable patient population (chronic stroke with upper-limb impairment) and overlapping clinical channel, with both companies selling through physician prescription and DME reimbursement.
• Ekso Bionics: Ekso Bionics manufactures robotic exoskeletons (EksoNR, EksoGT) for stroke and spinal cord injury rehabilitation, used in clinical rehabilitation settings. Comparable in robotic rehabilitation technology and neurological patient population, though primarily clinic-based rather than at-home like Kandu.
• Flint Rehab: Flint Rehab develops at-home stroke and neurological rehabilitation devices including MusicGlove and FitMi, prescribed for hand and arm motor recovery in chronic stroke patients. Directly comparable in targeting the chronic stroke upper-extremity rehabilitation market with prescribed, clinically-validated devices.
• Kinova Robotics: Kinova produces robotic exoskeletons and assistive devices (JACO arm, robotic rehabilitation platforms) for individuals with mobility and upper-limb impairments. Comparable in robotic assistive technology and overlapping application in upper-limb rehabilitation for neurological conditions.
• Bioness (Bioventus): Bioness (now part of Bioventus) is a direct peer in neurological rehabilitation devices, with functional electrical stimulation products (L300 Go, H200 Wireless) for foot drop and hand function in stroke and other neurological conditions. Highly comparable as a prescribed, FDA-cleared rehabilitation device targeting chronic stroke motor recovery through electrophysiological technology.

Emerging players

• Blackrock Neurotech: Blackrock Neurotech is a brain-computer interface company developing implantable neural interfaces for research, clinical, and consumer applications. Comparable in BCI technology category, with a different form factor (implantable array) and primarily research/clinical-trial focus rather than at-home stroke rehabilitation.
• Bionik Laboratories: Bionik Laboratories developed robotic rehabilitation devices (InMotion ARM) for upper-extremity motor recovery following stroke. Comparable in robotic rehab technology for stroke motor recovery, though historically clinic-based and has faced commercialization challenges.

Broad incumbents

• Hinge Health: Hinge Health is a broader digital musculoskeletal (MSK) platform combining wearable sensors, app-based exercise therapy, and human coaching for back, joint, and post-surgical rehab. Comparable as a digital rehabilitation platform with employer and payer distribution, but addresses a much broader MSK population rather than specializing in stroke.
• Sword Health: Sword Health is a digital physical therapy platform combining AI motion tracking, wearable sensors, and clinician oversight for MSK conditions. Comparable as a digital rehabilitation platform serving payers and employers, but broader scope than stroke and uses a different (motion-tracking) technology than BCI.
• Synchron: Synchron is a brain-computer interface company developing a minimally invasive (endovascular) BCI for patients with severe paralysis. Comparable in BCI technology category, though focused on assistive communication/mobility for severe paralysis rather than stroke rehabilitation motor recovery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/kandu-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tiger Kandu LLC